Importantly, we found that tumors that were responsive to anti-PD-1 treatment exhibited a significant increase in ferroptosis compared to that of the nonresponsive group, indicating that the level of ferroptosis may affect the efficiency of PD-1 treatment in CRC. Here, PDCD1 is linked to colorectal carcinoma.